Hourly Consulting
Scoped on your call
A second opinion without commissioning a full valuation. Physicians use it for an independent read on a private equity offer, a partner buy-in, or a purchase they are weighing before signing a letter of intent.
Inland Empire · Southern California
Outpatient demand is growing faster here than almost anywhere in California. Surgery center owners should know what that growth is worth.
Surgery center economics follow population, and no large California market is adding population faster than the Inland Empire. Health systems including Kaiser, Loma Linda University Health, Riverside University Health System, and Dignity Health are all competing for outpatient capacity, procedures keep migrating out of hospitals, and the region's case volume grows with every new rooftop in Temecula, Menifee, and Eastvale. Valuing a center here still requires the discipline of our ASC valuation methodology: payer mix analysis, physician concentration quantified rather than guessed, out-of-network exposure normalized, and controlling versus minority interests treated correctly. Appraisals are prepared in compliance with USPAP.
Physician buy-ins and partner redemptions, valued under the operating agreement's actual terms. Pre-sale valuations that flow into a confidential sale process. Divorce and dispute matters at the Detailed Report tier. Lender-required appraisals on financing timelines.
We scope the right tier on your discovery call, so you never pay for more report than your purpose requires.
Scoped on your call
A second opinion without commissioning a full valuation. Physicians use it for an independent read on a private equity offer, a partner buy-in, or a purchase they are weighing before signing a letter of intent.
Starting at $4,950
A professionally developed conclusion of value in a streamlined report, grounded in normalized financials and real market data, and prepared in compliance with USPAP. The right fit for exit planning, pricing a sale, or anchoring a partner buy-in. Our most common engagement.
Starting at $8,950
The gold standard, with full documentation of data, methodology, and assumptions, prepared in compliance with USPAP. Required where the number will be challenged: divorce, shareholder disputes, and gift & estate tax filings.
The purpose of a valuation changes the standard of value, the report depth, and sometimes the conclusion itself. Choose your situation:
Selling
Know what your surgery center is truly worth before a buyer tells you what they want to pay.
Learn morePartner Buy-In & Buy-Out
A fair, independent number both partners can trust, whether buying in or cashing out.
Learn moreDivorce
Court-ready, USPAP-compliant valuations for marital dissolution involving a surgery center.
Learn moreShareholder Dispute
Independent, litigation-ready valuations when partners disagree about what the ASC is worth.
Learn moreSBA Loan
Lender-ready business valuations that satisfy SBA SOP requirements without slowing your closing.
Learn moreGift & Estate Tax
IRS-defensible valuations for gifting, succession, and estate planning involving ASC interests.
Learn moreA confidential conversation about your surgery center, the interest being valued, your timeline, and the purpose of the valuation. We scope the right report tier before you commit to anything.
We interview ownership and normalize the earnings base. Out-of-network revenue and related-party facility, management, and anesthesia arrangements all get restated. Typical turnaround: 1–2 weeks.
You receive a defensible, USPAP-compliant conclusion of value for the specific interest being valued, whether controlling or minority. We walk you through it line by line, and the report is documented to withstand scrutiny from a buyer, a court, a partner, or a lender.
Independent, defensible, and fast.
Real Google reviews from physicians and practice owners we have served. Read them on Google
“As a physician with partnership transaction of medical practice, he was an exceptional to guide me and advise me. He showed not only professionalism but also his eagerness to help and guide me through. Highly recommend him for any business valuation and transaction.”
Dr. Kyong Kim
Partnership transaction
“Fantastic valuation/appraisal specialist. I reached out to Alexey to help me evaluate a medical practice buy-in on short notice. He was able to work me into his schedule and accommodate my timeline despite how busy he was and provided crucial insight into helping me decide my next steps.”
Dr. Xuan Cao
Medical practice buy-in
“They get 5 stars across the board. Alexey was extremely thorough and detailed oriented. He did a deep dive into my practice’s financials, coding and practice history. He was easily approachable and prompt in answering questions and in completing the Appraisal. I am confident in the results and I would highly recommend him to any physician/practice for an appraisal.”
Dr. Robert Sacks
Ophthalmology practice
“I called Nechay as I was navigating the potential of selling my practice, and I had a lot of questions about my various offers for sale. Nechay was so responsive, methodical, and educational. He really allowed me to understand the landscape of selling my practice. He is an effective communicator, very patient on the phone and obviously extremely knowledgeable. I will be hiring him to help complete my transactions!”
Dr. Garima Lal
Evaluating sale offers
“I hired Nechay Appraisals to value my ophthalmology practice last year and couldn’t have been more impressed. From start to finish, Alexey was fantastic to work with. The end result was a highly professional and polished valuation report that provided valuable insights on the current state of my business.”
Dr. David Salvay
Ophthalmology practice valuation
“Alexey has been an excellent asset in evaluating our practice. His experience and practice suggestions have helped us tremendously. His working knowledge of medical practice evaluation and application of these skills is second to none. He is always readily available at a moment’s notice.”
Dr. Elio Vento
Practice evaluation
“Very attentive. Quick to respond. Knowledgeable.”
Dr. Betty Daniels
“Very professional, responsive and creates an excellent report and is accessible. Thank you!”
Dr. Daniel Laroche
“Alexey is very professional and a pleasure to work with. I was under time constraints and he completed his review on time despite those additional pressures.”
Dr. Charles Jackson
“Nechay listened carefully and provided objective feedback tailored to my specific situation. His honest communication and expertise made a complex process much easier. I highly recommend him.”
Dr. Maria Soledad Romero
“Highly recommend! From start to finish, he demonstrated expertise, professionalism, and genuine care. Not only did he deliver a thorough, well-researched valuation report, but he also took the time to explain key findings, offer strategic advice, and answered all our questions — even talked to our accountant and bookkeeper to dig deep into our situation.”
Dr. Alicia Sanchez
Medical practice valuation
“We hired Nechay Appraisals to value our ophthalmology practice the year before last and couldn’t have been more impressed. From start to finish, Alexey was fantastic to work with. He was very organized and very patient with us as we gathered what he needed. Every week he would check in to make sure everything was on track. We are getting ready to utilize his services again and are looking forward to working with him.”
Jenna Keller
Ophthalmology practice valuation
“I greatly appreciate the help from Alexey. The process was easy and the information was invaluable. The data provided was comprehensive and gave me perspective of my company that I was not aware of. I highly recommend Alexey and his company.”
Dr. Linh Ngo
Medical practice valuation
Yes, if the evidence supports it. Documented case-trend growth in a growing service area is exactly what the income approach exists to capture. What we will not do is price optimism without numbers behind it.
We quantify it: case volume by surgeon, age and succession outlook, and the realistic recruiting timeline in this market. Concentration risk is priced, not ignored, and mitigation like a signed incoming partner changes the number.
Yes. Interest-level engagements are routine: enterprise value first, then the interest under the operating agreement's terms, with control and marketability treatment documented. Typically one to two weeks.
Growth priced with evidence, risk priced with honesty.
All inquiries are kept strictly confidential.